ImmuCell Stock (NASDAQ: ICCC) stock price, news, charts, stock research, profile.
Open | $3.65 |
Close | - |
Volume / Avg. | 19.00K / 35.52K |
Day Range | $3.60 - $3.77 |
52 Wk Range | 3.34 - 5.64 |
Market Cap | $28.28M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 0.29% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ImmuCell (NASDAQ:ICCC) through any online brokerage.
Other companies in ImmuCell’s space includes: Lumos Pharma (NASDAQ:LUMO), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT), Geovax Labs (NASDAQ:GOVX) and Palatin Techs (AMEX:PTN).
There is no analysis for ImmuCell to provide a consensus price target.
The stock price for ImmuCell (NASDAQ: ICCC) is $3.61 last updated September 23, 2024 at 3:35 PM EDT.
There are no upcoming dividends for ImmuCell.
ImmuCell’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for ImmuCell.
ImmuCell is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.